Semaglutide linked to higher risk of vision problems, FDA data analysis shows

	Ophthalmology & Optometry
	The latest ophthalmology / optometry news from News Medical

	Semaglutide linked to higher risk of vision problems, FDA data analysis shows Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher reporting rate of vision impairment. The findings call for further study into the ocular risks of this widely prescribed diabetes and weight loss drug.

	Breakthrough research reveals gut-eye connection in vision loss Inherited retinal degeneration (IRD) encompasses various disorders characterized by progressive loss of retinal photoreceptor cells, ultimately leading to vision loss and blindness.

			Why measles is back in the U.S. and what doctors must know now Measles is making a troubling comeback in the U.S., driven by declining vaccination rates and rising vaccine hesitancy. Pediatric infectious disease experts provide clinical guidance to help healthcare providers recognize, manage, and prevent measles in today’s outbreak-prone environment.

			Breakthrough protein offers new hope for pulmonary sarcoidosis treatment Pulmonary sarcoidosis is a lung disease characterized by granulomas-tiny clumps of immune cells that form in response to inflammation.

			Scientists unveil dynamic structure of protein key to vision Scientists have for the first time looked deep into the protein structure that may determine our vision - and discovered that it is much more dynamic than previously thought.

	New insights into how myasthenia gravis antibodies disrupt muscle function People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around.

	Optimizing prescription vision for next-generation AR MR and smart glasses Explore how advanced prescription vision compensation enhances clarity and precision in AR, MR, and smart glasses.

	New liver directed treatment improves outcomes for rare eye cancer A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver.

	Reserpine shows promise in treating retinitis pigmentosa in rat studies New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025